ArticleInternational journal of genomics2023

OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration.

Shuzhang Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.